drugset / Trial / NCT06301308

A Novel Application of 2% Lidocaine Injection for Male Rigid cycstoscopy-a Patient-blinded Randomised Trial

NCT06301308 ↗

RandomizedFactorialSingle-blindSupportive care

Summary

The goal of this clinical trial is to learn about a novel application of lidocaine injection in male patients who needs rigid cycstoscopy test. The main question it aims to answer is:Does New Application of Lidocaine Liquid Provide Pain Relief for Patients During Cystoscopy? Before the cycstoscopy,Participants will be randomly divided into three different anesthesia mode groups,namely are Group A (intraurethral lidocaine gel alone), Group B (intraurethral lidocaine gel + lidocaine 2% injection), and Group C (intraurethral lidocaine gel + liquid paraffinl).Patients only need to prepare and cooperate according to routine surgical operations,which is group B or group C.

Timeline

Start
2023-10-01
Primary completion
2024-02-29
Completion
2024-02-29

Outcome

Outcome not reported

Stopped (Enrollment): “The standard measures of anaesthesia in cystoscopy are not uniform internationally, and given this, we were unable to recruit the first participant in the study.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Lidocaine Other / unclassified 2 % Other
Comparator Lidocaine Other / unclassified 10 ml Other